$120.82
1.030.86%
At Close: -
$120.82
00.00%
After Hours: 4:00 PM EDT
15 minutes delayed
Repligen
RGENNASDAQ
Overview Rating
Speculative
want to know what
the Bulls & Bears Say?
Repligen (NASDAQ:RGEN) Stock Quotes, Forecast and News Summary
Repligen Stock (NASDAQ: RGEN) stock price, news, charts, stock research, profile.
| Open | $120.00 |
| Close | $120.82 |
| Volume / Avg. | 899.96K / 643.61K |
| Day Range | 117.63 - 120.98 |
| 52 Wk Range | 110.45 - 211.13 |
| Market Cap | $6.75B |
| P/E Ratio | 443.67 |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 31 |
| Short Interest | 8.89% |
| Days to Cover | 5.32 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Repligen Corp.
Sector
Health Care
Industry
Life Sciences Tools & Services
Repligen Corp is a global life sciences company. It develops and commercializes innovative bioproces...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Repligen (RGEN) stock?
You can purchase shares of Repligen (NASDAQ:RGEN) through any online brokerage.
Who are Repligen (RGEN) competitors?
Other companies in Repligen’s space includes: Medpace Hldgs (NASDAQ:MEDP), Agilent Technologies (NYSE:A), 10x Genomics (NASDAQ:TXG), BioLife Solns (NASDAQ:BLFS) and Waters (NYSE:WAT).
What is the target price for Repligen (RGEN) stock?
There is no analysis for Repligen.
What is the forecast for Repligen (RGEN) stock?
Repligen has a consensus price target of $174.38.
Current stock price for Repligen (RGEN)?
The stock price for Repligen (NASDAQ: RGEN) is $120.82 last updated Today at July 9, 2024 at 4:00 PM EDT.
Does Repligen (RGEN) pay a dividend?
There are no upcoming dividends for Repligen.
When is Repligen (NASDAQ:RGEN) reporting earnings?
Repligen’s Q2 earnings are confirmed for Wednesday, July 31, 2024.
Is Repligen (RGEN) going to split?
There is no upcoming split for Repligen.
What sector and industry does Repligen (RGEN) operate in?
Repligen is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.